These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11326198)

  • 41. Gamma-hydroxybutyrate for sedation in children.
    Meyer S; Gottschling S; Gortner L
    J Pediatr (Rio J); 2007; 83(4):387; author reply 386-7. PubMed ID: 17676245
    [No Abstract]   [Full Text] [Related]  

  • 42. [Severe delirium in withdrawal from chronic gamma-hydroxybutyric acid consumption].
    Proest G; Zschernack T; Stelzig M; Steinacher B
    Nervenarzt; 2009 May; 80(5):607-8. PubMed ID: 19252889
    [No Abstract]   [Full Text] [Related]  

  • 43. The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans.
    Bosch OG; Seifritz E
    Brain Res Bull; 2016 Sep; 126(Pt 1):47-60. PubMed ID: 26855327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Withdrawal syndrome in a depressed patient treated with trazodone.
    Menza MA
    Am J Psychiatry; 1986 Sep; 143(9):1195. PubMed ID: 3752308
    [No Abstract]   [Full Text] [Related]  

  • 45. Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena.
    Bianchi M; Musch B
    Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():139-45. PubMed ID: 2387981
    [No Abstract]   [Full Text] [Related]  

  • 46. A case series of pharmaceutical gamma-hydroxybutyrate in 3 patients with severe benzodiazepine-resistant gamma-hydroxybutyrate withdrawal in the hospital.
    van Noorden MS; Kamal RM; Dijkstra BA; Mauritz R; de Jong CA
    Psychosomatics; 2015; 56(4):404-9. PubMed ID: 25016356
    [No Abstract]   [Full Text] [Related]  

  • 47. The SHOT scale and measuring the severity of alcohol withdrawal in the emergency department.
    Livshits V; Rella J
    Acad Emerg Med; 2011 Apr; 18(4):447; author reply 448. PubMed ID: 21496153
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
    Wood DM; Brailsford AD; Dargan PI
    Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Propranolol, hallucinations, and sleep disturbance.
    Fleming PD; Drachman DA
    Am J Psychiatry; 1982 Apr; 139(4):540-1. PubMed ID: 7065308
    [No Abstract]   [Full Text] [Related]  

  • 50. [Changes in the bioelectric activity of the brain in patients with pulmonary tuberculosis during intolerance cycloserine].
    Shmelev NA; Shabalova LN
    Antibiotiki; 1970 Dec; 15(12):1120-5. PubMed ID: 5501372
    [No Abstract]   [Full Text] [Related]  

  • 51. Diazepam withdrawal syndrome: its prolonged and changing nature.
    Mellor CS; Jain VK
    Can Med Assoc J; 1982 Dec; 127(11):1093-6. PubMed ID: 7139456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurological aspects of alcoholism.
    Pearce JM
    Br J Hosp Med; 1977 Aug; 18(2):132, 134, 136-7 passim. PubMed ID: 890191
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-Hydroxybutyrate.
    White CM
    J Clin Pharmacol; 2017 Jan; 57(1):33-39. PubMed ID: 27198055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rebound insomnia in neuroleptic drug withdrawal neurophysiologic characteristics.
    van Sweden B
    Pharmacopsychiatry; 1987 May; 20(3):116-9. PubMed ID: 2885865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse.
    Mahr G; Bishop CL; Orringer DJ
    Psychosomatics; 2001; 42(5):439-40. PubMed ID: 11739915
    [No Abstract]   [Full Text] [Related]  

  • 58. Gamma-hydroxybutyrate versus chlorprothixene/phenobarbital sedation in children undergoing MRI studies.
    Meyer S; Gottschling S; Georg T; Lothschütz D; Graf N; Sitzmann FC
    Klin Padiatr; 2003; 215(2):69-73. PubMed ID: 12677545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
    Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
    Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute psychosis after mefloquine: a case report.
    Sowunmi A
    East Afr Med J; 1994 Dec; 71(12):818-9. PubMed ID: 7705258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.